Trials to watch: Phase III TB vaccines and MDR-TB treatments
GlobalData epidemiologists project TB cases across the 16 major markets to reach 4.5 million by 2033.
AD/PD 2026: Roche’s prasinezumab shows promise on PD progression with five-year data
Insmed eyes Arikayce label expansion on Phase IIIb lung disease success
AD/PD 2026: AL-S Pharma’s AP‑101 data backs approach to target misfolded SOD1 in ALS
Avalyn initiates Phase II AURA trial for idiopathic pulmonary fibrosis
Sensorion reports six-month Audiogene trial results for gene therapy
Analysis
View More
Themes
View MoreKidney disease risk higher after Covid infection than after influenza infection
Researchers at the Penn State College of Medicine sought to determine the effects of Covid-19 and influenza on the risk of acute and chronic kidney disease.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View more
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
CinnaGen Enters EU Market with EMA Approval for Zandoriah®
Oncology trial systems debut at SCOPE 2026 as AI adoption accelerates
Biorce secures $52.5m in Series A to expand AI clinical trial tech
Revealing the human and business cost of clinical trial inefficiencies for Data Managers and CRAs